RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?
RAPT Therapeutics Ownership Summary
RAPT Therapeutics is owned by 76.60% institutional investors, 1.84% insiders, and 21.56% retail investors. Fmr is the largest institutional shareholder, holding 13.55% of RAPT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.77% of its assets in RAPT Therapeutics shares.
RAPT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | RAPT Therapeutics | 76.60% | 1.84% | 21.56% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 5.24M | 13.55% | $15.97M |
| Vanguard group | 3.11M | 8.05% | $9.48M |
| Column group | 2.68M | 6.94% | $8.18M |
| Blackrock | 2.44M | 6.32% | $7.44M |
| Kingdon capital management | 1.73M | 4.47% | $5.26M |
| Morgan stanley | 1.18M | 3.05% | $3.60M |
| Deutsche bank ag\ | 932.54K | 2.41% | $2.84M |
| D. e. shaw | 907.41K | 2.35% | $2.77M |
| Federated hermes | 796.08K | 2.06% | $2.43M |
| Point72 asset management | 707.30K | 1.83% | $2.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 2.68M | 11.47% | $8.18M |
| Kingdon capital management | 1.73M | 0.56% | $5.26M |
| Ghost tree capital | 300.00K | 0.29% | $915.00K |
| Sio capital management | 315.00K | 0.26% | $960.75K |
| Euclidean capital | 657.90K | 0.25% | $2.01M |
| Altium capital management lp | 200.00K | 0.25% | $610.00K |
| Octagon capital advisors lp | 292.00K | 0.14% | $890.60K |
| Redmile group | 536.68K | 0.10% | $1.64M |
| Cormorant asset management, lp | 496.75K | 0.09% | $1.52M |
| Alphabet | 540.27K | 0.08% | $1.65M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 707.30K | 0.01% | 706.90K |
| Deutsche bank ag\ | 932.54K | 0.00% | 643.03K |
| D. e. shaw | 907.41K | 0.00% | 637.27K |
| Vanguard group | 3.11M | 0.00% | 615.42K |
| Federated hermes | 796.08K | 0.01% | 520.37K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 208.50K | 0.00% | -1.82M |
| Perceptive advisors | - | - | -1.22M |
| Morgan stanley | 1.18M | 0.00% | -726.44K |
| Ardsley advisory partners lp | - | - | -500.00K |
| Ally bridge group (ny) | - | - | -420.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Altium capital management lp | 200.00K | 0.25% | 200.00K | $610.00K |
| Norges bank | 100.30K | - | 100.30K | $305.92K |
| Pdt partners | 97.81K | 0.03% | 97.81K | $298.31K |
| Aqr capital management | 88.37K | 0.00% | 88.37K | $269.54K |
| Thrivent financial for lutherans | 53.99K | 0.00% | 53.99K | $164.00K |
Sold Out
| Holder | Change |
|---|---|
| Farther finance advisors | -2.00 |
| Nelson, van denburg & campbell wealth management group | -7.00 |
| Gamma investing | -27.00 |
| Quadrant capital group | -38.00 |
| Nisa investment advisors | -39.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 95 | -18.10% | 29,799,990 | -6.32% | 76 | 1.13% | 38 | -32.14% | 27 | -18.18% |
| Jun 30, 2024 | 116 | -17.14% | 31,809,166 | -0.17% | 82 | 1.20% | 56 | -25.33% | 33 | 10.00% |
| Mar 31, 2024 | 140 | 19.66% | 31,861,728 | -8.92% | 83 | 1.00% | 75 | 19.05% | 30 | -14.29% |
| Dec 31, 2023 | 117 | 15.84% | 34,982,126 | 0.63% | 91 | 1.11% | 63 | 50.00% | 35 | -7.89% |
| Sep 30, 2023 | 101 | 1.00% | 34,763,427 | 2.09% | 90 | 1.15% | 42 | -12.50% | 38 | 15.15% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.01M | 5.77% | 11.83K |
| Fidelity Growth Compy Commingled Pl O | 2.00M | 5.73% | - |
| Fidelity Growth Company Fund | 1.52M | 4.34% | -3.22K |
| Vanguard Total Stock Mkt Idx Inv | 1.12M | 3.22% | - |
| Fidelity Select Biotechnology | 802.70K | 2.30% | - |
| iShares Russell 2000 ETF | 730.79K | 2.09% | -1.64K |
| Fidelity Growth Company K6 | 499.30K | 1.43% | -8.62K |
| Federated Hermes MDT Small Cap Core IS | 461.23K | 1.32% | - |
| Federated Hermes MDT SCC Institutional | 461.23K | 1.32% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 458.85K | 1.31% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 05, 2024 | Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | Sell | $20.46K |
| Dec 21, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $54.20K |
| Nov 28, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $20.58K |
| Oct 03, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $39.42K |
| Aug 18, 2023 | HO WILLIAM | Chief Medical Officer | Sell | $47.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 1 |
| 2023 Q4 | - | 3 |
| 2023 Q3 | - | 1 |
RAPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools